Investment
Features
FeesSafety
Academy
More
Pluang+

OCC defends review of World Liberty Financial's crypto bank charter amid political scrutiny.

Market News
05 Jun 2026
Crypto Briefing
View Source
Neutral
pluang ai news

Jonathan Gould, Comptroller of the Currency, defended the OCC's review process of World Liberty Financial's application for a national trust bank charter before Congress, pushing back against Democratic accusations of favoritism due to the firm's Trump ties. The charter would allow World Liberty Financial to issue a USD1 stablecoin and manage digital asset services, a significant move as the OCC has approved several crypto trust charters since late 2025. This development signals growing federal legitimacy for crypto firms, potentially reshaping the stablecoin market dominated by USDT and USDC. The review occurs alongside ongoing regulatory framework development under the GENIUS Act, which aims to set clear rules for stablecoin issuers.

More News

ICF International sees 24% stock upside with 2026 growth driven by energy, AI, and federal projects.

ICF International sees 24% stock upside with 2026 growth driven by energy, AI, and federal projects.

Analyst Barrington raised ICF International's price target to $110, suggesting a 24.45% upside from $88.39. The company expects 3% revenue growth and 5% non-GAAP EPS growth in 2026, fueled by energy, AI, and federal modernization efforts. Q2 2026 ear...

Analyst Insights
Bullish
4 hours ago
HSBC upgrades YPF to Buy on strong Q2 results and $51B LNG expansion plan

HSBC upgrades YPF to Buy on strong Q2 results and $51B LNG expansion plan

HSBC has upgraded YPF's rating to Buy following strong Q2 2026 results, including a 41.7% revenue increase to $6.57 billion and earnings per share of $3.07, surpassing estimates. YPF raised its 2026 adjusted EBITDA guidance to $8 billion and aims for...

Analyst Insights
Bullish
4 hours ago
Vivos Therapeutics beats Q2 EPS estimates but misses revenue, faces liquidity concerns.

Vivos Therapeutics beats Q2 EPS estimates but misses revenue, faces liquidity concerns.

Vivos Therapeutics reported Q2 2026 earnings per share of -$0.31, beating analyst expectations of -$0.42, but its revenue of $5.15 million fell short of the $5.63 million estimate. The company, focused on sleep apnea treatments, sees growing patient ...

Company Fundamentals
Neutral
4 hours ago
Ether.fi shows rising fees and TVL, with token holders climbing but no Q3 buybacks yet.

Ether.fi shows rising fees and TVL, with token holders climbing but no Q3 buybacks yet.

Ether.fi's protocol activity is growing, evidenced by rising fees reaching $2.8 million weekly and total value locked (TVL) increasing to $3.532 billion. The number of token holders has also grown to 131,940, indicating sustained demand despite no bu...

Protocol Fundamentals
Bullish
4 hours ago
Major stocks fall sharply amid mixed earnings and negative outlooks, signaling broader market concerns.

Major stocks fall sharply amid mixed earnings and negative outlooks, signaling broader market concerns.

Several leading stocks, including SoundThinking, TSS, and ADI Global Distribution, dropped significantly due to factors like lowered revenue forecasts and disappointing quarterly results. SoundThinking fell over 25% after cutting its revenue outlook ...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App